You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

CLINICAL TRIALS PROFILE FOR COSOPT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Cosopt

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00140049 ↗	A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma	Completed	Pfizer	Phase 4	2005-07-01	To demonstrate the statistical non inferiority of the combination of latanoprost and timolol given in the evening time once a day vs the combination of dorzamalide and timolol twice a day based on intraocular pressure measurements at 8 AM, 12 noon & 4 PM during a 12 week treatment.
NCT00140049 ↗	A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma	Completed	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4	2005-07-01	To demonstrate the statistical non inferiority of the combination of latanoprost and timolol given in the evening time once a day vs the combination of dorzamalide and timolol twice a day based on intraocular pressure measurements at 8 AM, 12 noon & 4 PM during a 12 week treatment.
NCT00273429 ↗	Cosopt Versus Xalatan	Completed	Pharmaceutical Research Network	Phase 4	2005-04-01	To compare the 24-hour efficacy and safety, measured every three hours, of the dorzolamide/timolol fixed combination given twice daily versus latanoprost and placebo each given once daily.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Cosopt

Condition Name

Chart
Table

Condition Name for Cosopt
Intervention	Trials
Ocular Hypertension	19
Glaucoma	15
Open-Angle Glaucoma	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Cosopt
Intervention	Trials
Glaucoma	27
Ocular Hypertension	20
Hypertension	15
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Cosopt

Trials by Country

Map
Table

Trials by Country for Cosopt
Location	Trials
United States	23
Canada	4
Greece	3
Mexico	2
Italy	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Cosopt
Location	Trials
Pennsylvania	3
Massachusetts	3
Michigan	2
Indiana	2
Texas	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Cosopt

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Cosopt
Clinical Trial Phase	Trials
Phase 4	18
Phase 3	5
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Cosopt
Clinical Trial Phase	Trials
Completed	28
Unknown status	4
Terminated	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cosopt

Sponsor Name

Chart
Table

Sponsor Name for Cosopt
Sponsor	Trials
Alcon Research	9
Merck Sharp & Dohme Corp.	6
Pharmaceutical Research Network	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Cosopt
Sponsor	Trials
Other	24
Industry	23
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.